...
首页> 外文期刊>Artificial Organs >Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.
【24h】

Removal of the uremic retention solute p-cresol using fractionated plasma separation and adsorption.

机译:使用分级血浆分离和吸附去除尿毒症保留溶质对甲酚。

获取原文
获取原文并翻译 | 示例

摘要

Removal of protein-bound uremic retention solutes, including p-cresol, by peritoneal dialysis and hemodialysis (HD) is limited. p-Cresol, mainly circulating as sulfate conjugate (p-cresyl sulfate [PCS]), is independently associated with mortality. Fractionated plasma separation and adsorption (FPSA) is a nonbiologic detoxification system for the treatment of liver failure. The FPSA clearance of uremic retention solutes is unknown. We studied PCS clearance by FPSA, using the Prometheus system. The neutral resin adsorbent and the anion exchange adsorbent bind PCS in vitro (reduction ratios [RRs] 37 and 70%). Ex vivo, the adsorbent mass removal (MR) (median 47.5 mg) contributes more than half to total MR (median 89.6 mg). In vivo, PCS RR during FPSA (50%) exceeded the RR during high flux HD (30%). We halted the study after four inclusions due to repeated thrombosis of the arterio-venous conduit. In conclusion, FPSA is a promising technique to improve clearance of protein-bound uremic retention solutes.
机译:腹膜透析和血液透析(HD)对结合蛋白的尿毒症保留溶质(包括对甲酚)的去除是有限的。对甲酚,主要以硫酸盐结合物(对甲酚硫酸盐[PCS])形式循环,与死亡率独立相关。分级血浆分离和吸附(FPSA)是用于治疗肝衰竭的非生物排毒系统。尿毒症保留溶质的FPSA清除率未知。我们使用Prometheus系统通过FPSA研究了PCS间隙。中性树脂吸附剂和阴离子交换吸附剂在体外结合PCS(还原率[RRs] 37和70%)。在体外,吸附剂质量去除(MR)(中值47.5 mg)占总MR(中值89.6 mg)的一半以上。在体内,FPSA期间的PCS RR(50%)超过了高通量HD期间的RR(30%)。由于动静脉导管反复血栓形成,我们在四个夹杂物后停止了研究。总之,FPSA是提高蛋白结合的尿毒症保留溶质清除率的有前途的技术。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号